Health Condition 1: null- hyper pigmentation/dark spots of the face and neck.
Conditions
Interventions
Intervention1: IDC Image blanc products
IMAGE BLANC- complexion lightener- corrective anti aging serum
IMAGE BLANC- spot lightener â?? anti spots concentrate for targeted application: Appropriate amo
Sponsors
Glenmark Pharmaceuticals Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Subjects with hyper pigmentation/dark spots of the face and neck. Age group: 30 years and above Willing to restrain from prolonged exposure to the sun for the length of the study Available for the entire duration of the study
Exclusion criteria
Exclusion criteria: Hypersensitivity to any ingredients Pregnant and lactating women. Subjects who are already applying anti-aging, skin lightening or AHA (Alpha hydroxy acids) based or retinol based cosmetics or have applied any of these in the last 3 months. Subjects with dermatological disorder of face that may interfere with study evaluation. Subjects who have undergone any surgical treatment of the face.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improvement in spots darkenss MASI scoring Physicians Global Assessment Grade for improvement in complexion / dark spots on the face and neck Patients Global Assessment Grade for improvement in complexion / dark spots on the face and neck Quality of life Questionnaire Patient Satisfaction Questionnaire Timepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Amanjit Ahluwalia
Glenmark Pharmaceuticals Ltd
Outcome results
None listed